The U.S. Securities and Exchange Commission has cleared exchange-listing rules for proposed 3x leveraged Bitcoin and Ethereum futures funds from VS Trust, moving tickers BITH and ETHK closer to trading. The October 2 approval sets the stage for products designed to deliver three times their benchmark's daily return, before fees and expenses. According to VS Trust’s October 7 amended filing, the proposed Bitcoin fund carries a 1.85% annual management fee, with estimated trading-return breakevens of 1.98% for Bitcoin and 2.78% for Ethereum after incorporating other expenses and assumed interest on collateral.
However, analysts caution that these instruments reset daily, meaning investors cannot simply hold them as long-term bets. When the market falls, leverage erodes capital faster than the position size shrinks, forcing the fund to cut exposure and leaving less capital to participate in a rebound. The SEC’s own investor bulletin describes a real four-month scenario in which an index gained about 8% while a 3x daily-return fund lost 53%. Because the funds use futures, costs from rolling contracts and K-1 tax reporting may further separate actual returns from simply multiplying spot Bitcoin or Ethereum performance by three.
Separately, Bitcoin analytics firm Ecoinometrics warned that the momentum behind Bitcoin exchange-traded fund inflows may not be permanent. The firm distinguishes between momentum, the current pace of capital entering ETFs, and durable demand, the consistent institutional allocation needed for longer-term price support. Ecoinometrics has not called a peak or reversal, but frames the risk that today’s inflow strength may reflect a cyclical burst rather than a confirmed structural shift. If ETF buyers begin trading Bitcoin like any other risk asset, the flow tailwind could soften without any change to Bitcoin’s network fundamentals.
The combined picture is one of expanding access to amplified Bitcoin and Ethereum exposure alongside warnings that both leveraged ETF mechanics and ETF flow momentum require scrutiny. The products have not yet begun trading, but their approval adds another layer of complexity for investors trying to separate narrative-driven enthusiasm from durable, on-chain conviction.
